United States · Series B startup

Who invested in Personal Genome Disgnostics

One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Follow Personal Genome Disgnostics and see its new rounds in your feed.Start following

Funding summaryUpdated 27 Oct 2026

$75Mraised across 1 round since 2017, from 1 source

Latest round: Series B, $75MJan 2017
Investors: 5

See who backed them

The rounds

Jan 2017
Series B$75M
- Maryland Venture Fund
- Bristol Myers Squibb
- Co-win Healthcare
- NEA/ Inova
- Windham
Reported by FinSMEs

Everyone who backed them

Maryland Venture FundVC firm1round

Bristol Myers SquibbVC firm1round

Co-win Healthcareno record of our own yet1round

NEA/ Inovano record of our own yet1round

Windhamno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Personal Genome Disgnostics

Who invested in Personal Genome Disgnostics?

Personal Genome Disgnostics's investors include Maryland Venture Fund, Bristol Myers Squibb, Co-win Healthcare, NEA/ Inova and Windham.

How much has Personal Genome Disgnostics raised?

Personal Genome Disgnostics has raised $75M across 1 round since 2017.

When did Personal Genome Disgnostics last raise?

Personal Genome Disgnostics's most recent round was a Series B of $75M in Jan 2017.

What was Personal Genome Disgnostics's biggest round?

Its most recent round, $75M in Jan 2017, is also its largest on record.

Who backed Personal Genome Disgnostics first?

Personal Genome Disgnostics's first round on record, in Jan 2017, was backed by Maryland Venture Fund, Bristol Myers Squibb and Co-win Healthcare and 2 others.